Your browser doesn't support javascript.
loading
Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma.
Duvic, Madeleine; Pinter-Brown, Lauren C; Foss, Francine M; Sokol, Lubomir; Jorgensen, Jeffrey L; Challagundla, Pramoda; Dwyer, Karen M; Zhang, Xiaoping; Kurman, Michael R; Ballerini, Rocco; Liu, Li; Kim, Youn H.
Afiliação
  • Duvic M; MD Anderson Cancer Center, Houston, TX;
  • Pinter-Brown LC; University of California, Los Angeles, CA;
  • Foss FM; Smilow Cancer Center at Yale New Haven Hospital, New Haven, CT;
  • Sokol L; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;
  • Jorgensen JL; MD Anderson Cancer Center, Houston, TX;
  • Challagundla P; MD Anderson Cancer Center, Houston, TX;
  • Dwyer KM; Kyowa Hakko Kirin Pharma Inc, Princeton, NJ;
  • Zhang X; Kyowa Hakko Kirin Pharma Inc, Princeton, NJ;
  • Kurman MR; Kyowa Hakko Kirin Pharma Inc, Princeton, NJ;
  • Ballerini R; Kyowa Hakko Kirin Pharma Inc, Princeton, NJ;
  • Liu L; ReSearch Pharmaceutical Services, Inc, Fort Washington, PA; and.
  • Kim YH; Stanford Cancer Center, Stanford, CA.
Blood ; 125(12): 1883-9, 2015 Mar 19.
Article em En | MEDLINE | ID: mdl-25605368

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Cutâneo de Células T / Receptores CCR4 / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Cutâneo de Células T / Receptores CCR4 / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article